摘要
全世界大量的资源被投入到各种癌症的预防、诊断和治疗中。治愈癌症需要精确得诊断和严谨的治疗方案。传统的全身给药方法在不对正常组织产生毒性的前提下,通常不能完全去除有活性的癌细胞。因此,高效给药系统的开发在医疗保健中是很重要的。而且,分子成像在疾病治疗中发挥着越来越重要的革命性作用。分子成像和靶向给药方法的联合使用被称为影像引导给药(IGDD)的相关新领域提供了独特的机会。单光子发射计算机体层摄影(SPECT)是临床上应用最广泛的核成像方法,越来越多地被用于引导靶向治疗。材料科学的创新促进了基于聚合物、脂质体、胶束、树状大分子、微粒、纳米粒子等的高效药物载体的发展。这些运用了SPECT成像技术的药物载体的高效利用具有进行个性化治疗,减少传统治疗过程的侵袭力和快速监视疗效的潜力。SPECT-IGDD不仅用于治疗癌症,也能用于其他疾病。这里,我们简要回顾了SPECT-IGDD方法的最新进展,讨论了该领域的发展前景和挑战。
关键词: 癌症,化疗,影像引导给药,分子成像,单光子发射计算机体层摄影,治疗诊断学。
Current Drug Targets
Title:Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature
Volume: 16 Issue: 6
Author(s): Rubel Chakravarty, Hao Hong and Weibo Cai
Affiliation:
关键词: 癌症,化疗,影像引导给药,分子成像,单光子发射计算机体层摄影,治疗诊断学。
摘要: Tremendous resources are being invested all over the world for prevention, diagnosis, and treatment of various types of cancer. Successful cancer management depends on accurate diagnosis of the disease along with precise therapeutic protocol. The conventional systemic drug delivery approaches generally cannot completely remove the competent cancer cells without surpassing the toxicity limits to normal tissues. Therefore, development of efficient drug delivery systems holds prime importance in medicine and healthcare. Also, molecular imaging can play an increasingly important and revolutionizing role in disease management. Synergistic use of molecular imaging and targeted drug delivery approaches provides unique opportunities in a relatively new area called ‘image-guided drug delivery’ (IGDD). Single-photon emission computed tomography (SPECT) is the most widely used nuclear imaging modality in clinical context and is increasingly being used to guide targeted therapeutics. The innovations in material science have fueled the development of efficient drug carriers based on, polymers, liposomes, micelles, dendrimers, microparticles, nanoparticles, etc. Efficient utilization of these drug carriers along with SPECT imaging technology have the potential to transform patient care by personalizing therapy to the individual patient, lessening the invasiveness of conventional treatment procedures and rapidly monitoring the therapeutic efficacy. SPECT-IGDD is not only effective for the treatment of cancer but might also find utility in the management of several other diseases. Herein, we provide a concise overview of the latest advances in SPECT-IGDD procedures and discuss the challenges and opportunities for advancement of the field.
Export Options
About this article
Cite this article as:
Rubel Chakravarty, Hao Hong and Weibo Cai , Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450115666140902125657
DOI https://dx.doi.org/10.2174/1389450115666140902125657 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Exploring a Novel Target Treatment on Breast Cancer: Aloe-emodin Mediated Photodynamic Therapy Induced Cell Apoptosis and Inhibited Cell Metastasis
Anti-Cancer Agents in Medicinal Chemistry Role of ABC Transporters in the Chemoresistance of Human Gliomas
Current Cancer Drug Targets Current Application of Quantum Dots (QD) in Cancer Therapy: A Review
Mini-Reviews in Medicinal Chemistry The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine Evaluation of Melatonin Effect on Human Breast Cancer Stem Cells Using a Threedimensional Growth Method of Mammospheres
Anti-Cancer Agents in Medicinal Chemistry Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Roles of TRAF6 in Central Nervous System
Current Neuropharmacology Resveratrol and Ischemic Preconditioning in the Brain
Current Medicinal Chemistry Role of Cardiolipin in Mitochondrial Diseases and Apoptosis
Current Medicinal Chemistry Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis
Current Pharmaceutical Design Cytotoxic Activity of Polysubstituted 7-chloro-4-quinolinylhydrazone Derivatives
Letters in Drug Design & Discovery Current HPLC Methods for Assay of Nano Drug Delivery Systems
Current Topics in Medicinal Chemistry Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors’ Development
Current Medicinal Chemistry Correlation between Potassium Channel Expression and Sensitivity to Drug-induced Cell Death in Tumor Cell Lines
Current Pharmaceutical Design Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers
Current Medicinal Chemistry Targeting PPARalpha in Alzheimer's Disease
Current Alzheimer Research Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)